SCHEMBL6963211

SCHEMBL6963211

O=C(O)C(SCCCc1ccccc1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 3/20 0.50
HDAC1 Q13547 3/20 0.50
HDAC2 Q92769 3/20 0.50
HDAC8 Q9BY41 3/20 0.50
HDAC6 Q9UBN7 3/20 0.50
HDAC5 Q9UQL6 3/20 0.50
HDAC4 P56524 2/20 0.50
HDAC7 Q8WUI4 2/20 0.50
HDAC10 Q969S8 2/20 0.50
HDAC11 Q96DB2 2/20 0.50
HDAC9 Q9UKV0 2/20 0.50
MAPK1 P28482 1/20 0.50
ADRA1A P35348 1/20 0.50
SLC6A3 Q01959 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
GRIK1 P39086 1/20 0.49
NOS1 P29475 1/20 0.47
MAPT P10636 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
CYSLTR2 Q9NS75 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6953006 0.90 KEAP1 (0.48) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL7374971 0.80 SMN1; SMN2 (0.47) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL6954426 0.76 PPARG (0.49) SMN1; SMN2PPARGPPARACYP2C19POLB
SCHEMBL10484039 0.75 ANPEP (0.49) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL7078774 0.75 GRIK1 (0.57) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL1856639 0.75 GRIK1 (0.72) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL8534946 0.73 NOS1 (0.59) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL28721831 0.73 KEAP1 (0.47) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL11449291 0.73 SMN1; SMN2 (0.49) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL6578386 0.73 GRIK1 (0.59) HDAC3HDAC1HDAC2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed